FDA Announces In November 2007 That It Will Investigate Possible Link Between Maxipime And Increased Risk Of Death
November 20th, 2007 Posted by: Dr. Cox
A Medical Journal Article Published In May 2007 Suggested This Emerging Drug Safety Issue; Why Was There A Six-Month Delay In Starting This FDA Investigation?
In mid-November 2007 the FDA sent an MedWatch Email Alert to inform the public about an emerging drug safety issue involving Maxipime (Cefepime), an injectable antibiotic that was approved by the FDA in 1996.